IL2 and COVID-19: During the development of COVID-19, SARS-CoV-2 infection induced an excessive immune response and released a variety of pro-inflammatory cytokines through the JAK/STAT pathway, such as IL-2, IL-6, and granulocyte colony-stimulating factor signaling (Solimani et al., 2021).